Shuttle Pharmaceuticals Holdings, Inc. is a clinical stage pharmaceutical company, which engages in the development of novel therapies for cancer. The company is headquartered in Gaithersburg, Maryland and currently employs 9 full-time employees. The company went IPO on 2022-08-31. The firm is focused on improving the outcomes of cancer patients treated with radiation therapy (RT). The company is developing a pipeline of products designed to address cancer therapies as well as to extend to the new applications of radiation therapy. Its product candidates include Ropidoxuridine (IPdR), Ropidoxuridine and Tipracil (IPdR/TPI), SP-1-161, SP-2-225, and SP-1-303. Ropidoxuridine (IPdR) is its lead candidate radiation sensitizer for use in combination with RT to treat brain tumors (glioblastoma) and sarcomas. Ropidoxuridine and Tipracil (IPdR/TPI) is undergoing preclinical development for use as a radiation sensitizer for rectal cancers. SP-1-161 is a pre-clinical candidate lead histone deacetylase (HDAC) inhibitor, a radiation sensitizing candidate product. SP-2-225 is a pre-clinical class II b selective HDAC inhibitor that affects histone deacetylase HDAC6.
How did SHPH's recent EPS compare to expectations?
The most recent EPS for Shuttle Pharmaceuticals Holdings Inc is $, expectations of $.
How did Shuttle Pharmaceuticals Holdings Inc SHPH's revenue perform in the last quarter?
Shuttle Pharmaceuticals Holdings Inc revenue for the last quarter is $
What is the revenue estimate for Shuttle Pharmaceuticals Holdings Inc?
According to of Wall street analyst, the revenue estimate of Shuttle Pharmaceuticals Holdings Inc range from $ to $
What's the earning quality score for Shuttle Pharmaceuticals Holdings Inc?
Shuttle Pharmaceuticals Holdings Inc has a earning quality score of B/43.576237. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Shuttle Pharmaceuticals Holdings Inc report earnings?
Shuttle Pharmaceuticals Holdings Inc next earnings report is expected in
What are Shuttle Pharmaceuticals Holdings Inc's expected earnings?
Shuttle Pharmaceuticals Holdings Inc expected earnings is $, according to wall-street analysts.
Did Shuttle Pharmaceuticals Holdings Inc beat earnings expectations?
Shuttle Pharmaceuticals Holdings Inc recent earnings of $ expectations.